Charles J. Homcy, Chairman of Pharmaceuticals at BridgeBio Pharma, Inc. (BBIO), sold 20,000 shares at $36.00 ($720K) on 2020-02-10, disclosed to the SEC on 2020-02-12.
Open-market sale of $720k BBIO by Chairman of Pharmaceuticals. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BBIO | SELL | 2020-10-01 | $380K | — | Filing → |
| BBIO | SELL | 2020-09-29 | $6.7M | — | Filing → |
| BBIO | SELL | 2020-01-16 | $350K | — | Filing → |